A protein in tumor cells could be targeted to treat some types of aggressive cancer including brain, blood, skin, and kidney, new research has shown. The scientists, from the Wellcome Sanger Institute, University of Cambridge and Harvard University, have identified…
Read More
New therapeutic target for Huntington’s treatment
Huntington’s disease is caused by a mutation in the Huntingtin gene (HTT), which appears in adults and features motor, cognitive and psychiatric alterations. The origin of this disease has been associated with the anomalous functioning of the mutated protein mHTT,…
Read More
From trippy drugs to therapeutic aids – how psychedelics got their groove back
For many years, drugs such as LSD, psilocybin and Dimethyltryptamine (DMT) were viewed only as highly dangerous drugs. However, in recent years they have had a bit of rebrand. Now they’re believed by some to have the power to heal,…
Read More
How AI could make therapeutic decision-making for breast cancer more accurate, affordable
Imagine being a doctor and having a precocious resident permanently by your side, giving you brilliant insight into disease and helping you to identify the best treatment path for your patients. A team at Salesforce Research believes this scenario is…
Read More
How the regulator is regulated: Insight into immune-related protein holds therapeutic value
In immune-related disorders, therapy often involves identifying the molecules responsible for immune dysregulation and targeting them using drugs. This type of immune therapy is also used for cancer treatment, owing to the important role that immune cells play in cancer…
Read More
Novel therapeutic approaches for aggressive bone cancer
Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study led by geneticist Erwin Wagner has uncovered new insights into the disease mechanisms of OS, paving the way for potential new diagnostic and treatment strategies…
Read More
New therapeutic target for acute kidney injury identified
Acute kidney injury (AKI) is common and it happens fast. Unlike chronic kidney disease, which often takes years to manifest, patients with AKI experience a rapid deterioration of kidney function over hours or days. Critically ill patients and those undergoing…
Read More